How Will Existing Contracts With AbbVie Shape Payer Strategy Towards Shifting Market Share To Biosimilars?

P&T Session Immunology Biosimilars: MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts.